Imprimis Pharmaceuticals Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
7,643.10
10,118.10
15,899.00
19,087.00
11,985.00
Depreciation, Depletion & Amortization
5.70
85.30
610.00
1,406.00
1,765.00
Other Funds
0.20
13.10
269.00
17.00
206.00
Funds from Operations
4,502.50
7,418.10
11,468.00
10,532.00
9,503.00
Changes in Working Capital
63.50
362.70
325.00
683.00
700.00
Net Operating Cash Flow
4,438.90
7,055.40
11,143.00
11,215.00
8,803.00
Capital Expenditures
20.00
174.00
1,704.00
7,139.00
1,074.00
Sale of Fixed Assets & Businesses
-
-
-
-
113.00
Purchase/Sale of Investments
50.00
100.20
-
-
-
Net Investing Cash Flow
70.00
910.50
5,130.00
7,239.00
961.00
Issuance/Reduction of Debt, Net
-
10.40
9,240.00
267.00
893.00
Net Financing Cash Flow
10,052.60
598.10
10,747.00
24,672.00
4,930.00
Net Change in Cash
5,543.70
7,367.80
5,526.00
6,218.00
4,834.00
Free Cash Flow
4,459.00
7,229.40
12,662.00
18,102.00
9,575.00
Deferred Taxes & Investment Tax Credit
-
-
-
-
935.00
Net Assets from Acquisitions
-
636.40
3,426.00
100.00
-
Change in Capital Stock
10,052.80
621.70
1,238.00
24,922.00
4,243.00
About Imprimis Pharmaceuticals
View Profile
